Credit Suisse’s asset management has tied up another partnership, this time with a health care investment platform in Israel.
The health-care and life-science platform aMoon has agreed to a partnership with Swiss banking giant Credit Suisse. The deal will enable the Swiss bank to offer clients and investors access to the Israel venture fund, according to a statement released on Wednesday.
Based in Ra'anana, aMoon specializes in investments in digital health, medical devices as well as biopharma and focuses on providing capital to firms it considers undervalued. Credit Suisse plans to invest abound $250 million of client assets into the aMoon fund.
Ideal Launchpad
«This strategic partnership is perfectly timed to leverage the growing convergence of technology and healthcare,» said Yair Schindel, co-founder and managing partner of aMoon. «Breakthrough scientific research, innovative technology, and decades of digital health records make Israel an ideal launchpad for leading this global transformation in healthcare.»
